Diaceutics PLC (AIM:DXRX)

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Labs & Research	38.44M	32.16M	23.70M	19.50M	13.94M
Medical Labs & Research Growth	19.53%	35.69%	21.51%	39.88%	9.82%
Total	38.44M	32.16M	23.70M	19.50M	13.94M
Total Growth	19.53%	35.69%	21.51%	39.88%	9.82%

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North America	35.85M	29.54M	20.83M	14.45M	8.46M
North America Growth	21.37%	41.79%	44.13%	70.91%	40.13%
UK	766.00K	547.00K	352.00K	561.00K	555.00K
UK Growth	40.04%	55.40%	-37.25%	1.08%	2.21%
Europe	1.79M	1.89M	2.47M	2.70M	3.62M
Europe Growth	-5.44%	-23.36%	-8.38%	-25.59%	-14.61%
Asia and Rest of World	33.00K	181.00K	45.00K	1.79M	1.31M
Asia and Rest of World Growth	-81.77%	302.22%	-97.49%	37.08%	-30.24%
Total	38.44M	32.16M	23.70M	19.50M	13.94M
Total Growth	19.53%	35.69%	21.51%	39.88%	9.82%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 17, 2026

Data Sources Report a data error